HYBRID EVENT: You can participate in person at Tokyo, Japan from your home or work.
Colorectal Cancer

Colorectal cancer, also known as bowel cancer, is a type of cancer that starts in the colon or rectum, both part of the large intestine. It is a prevalent form of cancer, with risk factors including age, family history, certain genetic conditions, and lifestyle factors such as diet and physical activity. Colorectal cancer often develops from precancerous polyps, which are abnormal growths in the lining of the colon or rectum. Regular screenings, such as colonoscopies, play a crucial role in detecting and removing these polyps before they become cancerous.

Symptoms of colorectal cancer may include changes in bowel habits, blood in the stool, abdominal pain, and unexplained weight loss. Early stages of colorectal cancer may not manifest noticeable symptoms, underscoring the importance of routine screenings for early detection. Treatment options for colorectal cancer depend on the stage of the disease but often involve surgery, chemotherapy, and radiation therapy. Targeted therapies and immunotherapy are also emerging as valuable components of the treatment arsenal.

Preventive measures, such as maintaining a healthy lifestyle, regular exercise, and a diet rich in fruits, vegetables, and whole grains, can contribute to reducing the risk of colorectal cancer. Additionally, awareness campaigns emphasize the importance of early detection through screening, as early-stage colorectal cancer is more easily treatable. Colorectal cancer remains a significant public health concern, and ongoing research focuses on improving treatment modalities, enhancing early detection methods, and understanding the underlying genetic factors contributing to the disease.

Committee Members
Speaker at International Cancer Conference 2026 - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Speaker at International Cancer Conference 2026 - Patricia Tai

Patricia Tai

UpToDate, Canada
Speaker at International Cancer Conference 2026 - Jose Manuel Cervera Grau

Jose Manuel Cervera Grau

Preclinical Lab and Computational Drug Discovery Program, Relayer Biotech Inc, Spain

Submit your abstract Today

Facebook Twitter XTwitter Youtube
Watsapp